Medicine
Cortisporin TC 3 mg/10 mg/3.3 mg/0.5 mg per mL otic suspension
Cortisporin TC 3 mg/10 mg/3.3 mg/0.5 mg per mL otic suspension is a prescription medicine containing Colistin, Hydrocortisone, Neomycin and Thonzonium for otic use, marketed by Endo, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F).
Key facts
- Active ingredient (INN)
- Colistin, Hydrocortisone, Neomycin and Thonzonium
- Brand
- Cortisporin TC
- Strength
- 3 mg/10 mg/3.3 mg/0.5 mg per mL
- Dosage form
- Otic suspension
- Route
- Otic
- Packs
- 10 mL
- Marketing authorisation holder
- Endo
- Manufacturer
- Endo
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.32Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 3 June 2019
- Identifiers
- RxCUI 854992, 854997DailyMed set ID 9c6fc1c7-3350-42ae-b999-aca48e704bb1NDC 63481-529Application NDA050356
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 10 mL in 1 bottle, dropper | 63481-529-10 | Endo | 3 June 2019 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 17 May 1962 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Colistin, Hydrocortisone, Neomycin and Thonzonium is a fixed-dose combination of an aminoglycoside antibacterial and a corticosteroid indicated for the treatment of superficial bacterial infections of the external auditory canal, among other approved uses. MedsAcross supplies Colistin, Hydrocortisone, Neomycin and Thonzonium for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Colistin, Hydrocortisone, Neomycin and ThonzoniumFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Cortisporin TC prescribing information (Endo) · U.S. National Library of Medicine, DailyMed
Need Cortisporin TC 3 mg/10 mg/3.3 mg/0.5 mg per mL otic suspension for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.